You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Lupin Pharmaceuticals Inc.FDAMed source confidence · 80%Jun 22, 2026, 10:00 AM UTC · 16d ago
Lupin Pharmaceuticals Inc. — FDA Class II (D-0541-2026)
Case File
Lupin Pharmaceuticals Inc. is recalling 217,621 pen injectors due to contamination with particulate matter. This recall is classified as a safety issue. The affected products were distributed in the United States.
•Lupin Pharmaceuticals Inc. is recalling 217,621 pen injectors.
•The recall is due to contamination with particulate matter.
•This is classified as a Class I recall due to safety concerns.
•Patients should check their supplies and consult healthcare providers.
Why This Matters
Patients using the recalled pen injectors may face health risks due to contamination. They should stop using the product and consult their healthcare provider.